Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam.

Author information

Affiliations

  • 1. Operative Unit of Clinical Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
      Authors
    • Lombardo D 1
    • Ambretti S 1
    • Lazzarotto T 1
    • Gaibani P 1
    (4 authors)

ORCIDs linked to this article

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 03 Feb 2022, 28(5):749-751
https://doi.org/10.1016/j.cmi.2022.01.025 PMID: 35124257 

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.cmi.2022.01.025

Citations & impact 

Impact metrics

10
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/122057056
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/122057056

Article citations

Go to all (10) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

Ministero della Salute (1)